Article Details
Retrieved on: 2024-08-10 01:56:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
What: Shares of Immunomedics , a clinical-stage developer of monoclonal antibodies to help treat cancer and autoimmune disorders, rose as much as ...
Article found on: www.aol.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here